NYSE:OI
NYSE:OIPackaging

A Look At O-I Glass (OI) Valuation After Wave Of Positive Analyst Upgrades

O-I Glass (OI) has moved back into focus after a series of upbeat analyst calls, as Wells Fargo, Truist Securities and Citi all raised their expectations, citing cost savings and improved margins despite macro headwinds. See our latest analysis for O-I Glass. The recent wave of analyst upgrades has landed on a share price of US$15.33 that is already backed by firm momentum, with a 90 day share price return of 31.81% and a 1 year total shareholder return of 46.70%, even though the 3 year total...
TSE:4755
TSE:4755Multiline Retail

Is Rakuten Group (TSE:4755) Mispriced After Recent Reassessment Of Its Capital Position?

If you are wondering whether Rakuten Group's current share price reflects its true value, you are not alone. This article walks you through what the numbers are actually saying about the stock. The share price last closed at ¥1,003, with returns of 5.3% over the past 30 days, 9.7% over the past year and 61.3% over the last 3 years, while the year to date move and 7 day move both sit at 0.1% declines. Recent coverage has focused on Rakuten Group's ongoing efforts to balance its broad...
ASX:EMR
ASX:EMRMetals and Mining

Did Strong Okvau Output and Lower Dilution Just Shift Emerald Resources' (ASX:EMR) Investment Narrative?

Emerald Resources NL reported that its 100% owned Okvau Gold Mine in Cambodia produced 25,030 ounces of gold in the December 2025 quarter, with 21,372 ounces poured and 20,410 ounces sold at an average of US$4,118/oz, while a small parcel of options lapsed without operational impact. The strong quarterly production and sales figures underline the continued performance of Okvau as a key asset in Emerald Resources’ portfolio, while the option lapse slightly reduces potential future equity...
NasdaqGS:MKTX
NasdaqGS:MKTXCapital Markets

Why MarketAxess (MKTX) Is Down 5.3% After Transaction Fee Pressure Highlights Margin Mix Shift

In early January 2026, MarketAxess reported that transaction fees declined in December and the fourth quarter of 2025, largely due to a shift in the mix of trading protocols on its electronic bond trading platform. This fee pressure, alongside a long-running decline in gross and operating margins, has sharpened investor focus on the resilience of the company’s profitability model as its business mix evolves. We’ll now examine how the recent decline in transaction fees per million traded...
NYSE:TNK
NYSE:TNKOil and Gas

Assessing Teekay Tankers (TNK) Valuation After A Strong Multi Period Share Price Run

Teekay Tankers (TNK) is back on investor radar after recent share price moves, with the stock around $59.10 and trailing 1 year total return data and revenue figures providing a fresh basis for comparison. See our latest analysis for Teekay Tankers. The recent move in Teekay Tankers’ share price to around $59.10 comes after a strong 7 day share price return of 10.63% and a 90 day share price return of 20.29%, while the 1 year total shareholder return of 46.58% and very large 5 year total...
NYSE:ROL
NYSE:ROLCommercial Services

How Analyst Upgrades And Easing Short Interest At Rollins (ROL) Have Changed Its Investment Story

In recent days, Rollins Inc. saw its short interest as a percentage of float ease to 3.16%, while Executive Chairman John F. Wilson sold 1,520 shares to meet tax withholding obligations tied to restricted stock vesting. At the same time, multiple major analysts upgraded Rollins with positive views on demand and growth potential, signaling rising confidence in the company’s position relative to peers with higher short interest. Next, we’ll examine how these upbeat analyst upgrades, paired...
TSX:GEI
TSX:GEIOil and Gas

Gibson Energy (TSX:GEI) Valuation Check After Recent Share Price Moves And Cash Flow Scenarios

What Gibson Energy’s Recent Returns Say About the Stock Now With no single headline event driving attention, Gibson Energy (TSX:GEI) has been drawing interest as investors weigh its recent share performance against underlying fundamentals and income potential. See our latest analysis for Gibson Energy. At a share price of CA$24.61, Gibson Energy’s recent 1 day share price return of 1.7% sits against a softer year to date share price return of a 3.9% decline, while its 1 year total shareholder...
NYSE:OLN
NYSE:OLNChemicals

Is Olin (OLN) Exposing a Deeper Reliability Question With Its Weaker Q4 EBITDA Outlook?

Olin Corporation has recently cut its fourth quarter 2025 outlook, now expecting adjusted EBITDA of about US$67 million after operational issues at its Freeport, Texas chlor-alkali and vinyls facility and softer pipeline chlorine demand. This guidance revision highlights how operational reliability at key sites and demand volatility in core chlor-alkali markets can quickly influence Olin’s earnings profile. We’ll now examine how this weaker Q4 EBITDA guidance, driven largely by Freeport...
CPSE:CARL B
CPSE:CARL BBeverage

Carlsberg (CPSE:CARL B) Valuation Check As Swiss Pricing Dispute Tests Volume And Margin Trade Off

Carlsberg (CPSE:CARL B) is back in focus after its Swiss subsidiary, Feldschlösschen, temporarily stopped deliveries to Migros Group due to a pricing dispute. This has disrupted beer and soft drink supply across several Swiss retail chains. See our latest analysis for Carlsberg. Carlsberg’s pricing stand off in Switzerland comes against a backdrop of solid recent momentum, with an 11.7% 90 day share price return and a 26.05% 1 year total shareholder return, while longer term gains have been...
NasdaqCM:IMNM
NasdaqCM:IMNMBiotechs

How Varegacestat Phase 3 Results and NDA Plans Could Shape Immunome’s (IMNM) Late-Stage Strategy

Immunome recently granted stock options to three new hires under its 2024 Inducement Plan and highlighted strong Phase 3 RINGSIDE data for its lead cancer drug candidate, varegacestat, while also scheduling a presentation at the 44th Annual J.P. Morgan Healthcare Conference. Together, the positive clinical results, upcoming New Drug Application plans for varegacestat, and new equity-based hiring incentives underscore Immunome’s efforts to build a pipeline and team around its late-stage...
NYSE:MLM
NYSE:MLMBasic Materials

Is Martin Marietta Materials (MLM) Pricing Too Rich After Strong Multi‑Year Share Gains?

If you are wondering whether Martin Marietta Materials is priced attractively right now, the key question is how its current share price lines up against what you think the business is worth. The stock last closed at US$638.11, with returns of 2.5% over 7 days, 4.3% over 30 days, 0.6% year to date, 24.1% over 1 year, 84.8% over 3 years and 117.4% over 5 years. This naturally raises questions about the balance between opportunity and risk at today’s level. Recent attention on US...
NasdaqGS:AMPH
NasdaqGS:AMPHPharmaceuticals

Is Amphastar Pharmaceuticals (AMPH) Attractively Priced After Recent Share Price Weakness?

If you are wondering whether Amphastar Pharmaceuticals' current share price reflects its true worth, you are not alone. This article is designed to help you assess that. The stock last closed at US$27.74, with returns of 3.6% over the past week, 8.1% over the past month, 4.8% year to date and a 24.3% decline over the past year, alongside a 44.0% gain over five years. Recent attention on Amphastar Pharmaceuticals has been shaped by ongoing discussions around its product portfolio and position...
NasdaqGS:SBLK
NasdaqGS:SBLKShipping

A Look At Star Bulk Carriers (SBLK) Valuation After Recent Share Price Momentum

Star Bulk Carriers (SBLK) has been drawing attention after recent share price moves, with the stock closing at US$20.75. For investors, that price now sits against the backdrop of the company’s current profitability and fleet scale. See our latest analysis for Star Bulk Carriers. The recent share price return data points to building momentum, with a 1 day move of 1.17% and a 90 day share price return of 23.59%. The 1 year total shareholder return of 42.03% and 5 year total shareholder return...